Whether it's quitting smoking, reducing alcohol intake or making healthier dietary choices, many of us have habits we'd like to change. But it's really hard to know which treatment path to take.
Mar 5, 2019
0
2
Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids—and which might only suffer their side effects—with help from a dozen clinical ...
Feb 20, 2019
0
2
A high proportion of multidrug-resistant tuberculosis (TB) cases can be cured in conflict-affected communities with molecular diagnostics, shorter treatment periods and socioeconomic incentives, according to the results of ...
Feb 13, 2019
0
0
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease (AD).
Feb 11, 2019
0
7
Scientists are making important progress in the battle against a class of devilishly complex human pediatric brain cancers thanks to a new study from a team of Florida State University students and faculty.
Jan 30, 2019
0
4
Forty to 60 percent of all people treated for substance use disorders relapse, presenting a major challenge to treatment success. New research from the University of Pittsburgh School of Medicine shows that disrupting memories ...
Jan 22, 2019
0
130
In a phase three clinical trial, a drug called sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment, a significant increase in progression-free survival compared ...
Dec 19, 2018
0
13
A new way of identifying potential cancer drugs could streamline the development of therapies, following a discovery by scientists.
Nov 1, 2018
0
0
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.
Oct 17, 2018
0
14
Tafamidis is the first treatment to improve survival and reduce hospitalisations in a rare heart condition called transthyretin amyloid cardiomyopathy, according to late breaking research presented today in a Hot Line Session ...
Aug 27, 2018
0
0
